Teriparatide reduces the fracture risk associated with increasing number and severity of osteoporotic fractures

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 3, 2005, Pages 1583-1587

  Gallagher, J Christopher ^a   Genant, Harry K ^b,c   Crans, Gerald G ^d   Vargas, Socorro Juan ^e   Krege, John H ^d  

^a CREIGHTON UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SYNARC INC   (United States)

^d ELI LILLY AND COMPANY   (United States)

^e William W Backus Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARATHYROID HORMONE[1-34];

ADULT; AGED; ARTICLE; BONE FRAGILITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; EVALUATION; FEMALE; FRACTURE; FRACTURE REDUCTION; HUMAN; MAJOR CLINICAL STUDY; OSTEOPOROSIS; PREDICTION; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; STATISTICAL ANALYSIS; VERTEBRA FRACTURE; INCIDENCE; MIDDLE AGED; RISK FACTOR; SPINE FRACTURE; STATISTICAL MODEL;

AGED; FEMALE; HUMANS; INCIDENCE; LOGISTIC MODELS; MIDDLE AGED; OSTEOPOROSIS; PREVALENCE; RISK FACTORS; SPINAL FRACTURES; TERIPARATIDE;

EID: 15944389876     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-0826     Document Type: Article

References (17)

1. Ross PD, Davis JW, Epstein RS, Wasnich RD 1991 Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med 114:919-923
2. Klotzbuecher CM, Ross PD, Landsman PB, Abbott III TA, Berger M 2000 Patients with prior fractures have an increased risk of future fractures: a summary of the literature and statistical synthesis. J Bone Miner Res 15:721-739
3. Kanis JA, Johnell O, de Laet C, Johansson H, Oden A, Delmas P, Eisman J, Fujiwara S, Garnero P, Kroger H, McCloskey EV, Mellstrom D, Melton LJ, Pols H, Reeve J, Silman A, Tenenhouse A 2004 A meta-anaiysis of previous fracture and subsequent fracture risk. Bone 35:375-382
4. Delmas PD, Genant HK, Crans GG, Stock JL, Wong M, Siris E, Adachi JD 2003 Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial. Bone 33:522-532
5. Watts NB, Josse RG, Hamdy RC, Hughes RA, Manhart MD, Barton I, Calligeros D, Felsenberg D 2003 Risedronate prevents new vertebral fractures in postmenopausal women at high risk. J Clin Endocrinol Metab 88:542-549
6. Neer RM, Arnaud CD, Zanchetta JR, Prince R, Gaich GA, Reginster JY, Hodsman AB, Eriksen EF, Ish-Shalom S, Genant HK, Wang O, Mitlak BH 2001 Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 344:1434-1441
7. Vahle JL, Sato M, Long GG, Young JK, Francis PC, Engelhardt JA, Westmore M, Ma L, Nold JB 2002 Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone(1-34) for 2 years and relevance to human safety. Toxicol Pathol 30:312-321
8. Tashjian AH, Chabner BA 2002 Clinical safety of recombinant human parathyroid hormone (1-34) in the treatment of osteoporosis in postmenopausal women and men [commentary]. J Bone Miner Res 17:1151-1161
9. Vahle JL, Long GG, Sandusky G, Westmore M, Ma YL, Sato M 2004 Bone neoplasms in F344 rats given teriparatide [rhPTH(1-34)] are dependent on duration of treatment and dose. Toxicol Pathol 32:426-438
10. Genant HK, Wu CY, van Kuijk C, Nevitt MC 1993 Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137-1148
11. Agresti A 1990 Categorical data analysis. New York: Wiley & Sons
12. Efron B, Tibshirani RJ 1993 An introduction to the bootstrap. Monographs on statistics and applied probability. New York: Chapman, Hall; 57
13. Torgerson DJ, Campbell MK, Thomas RE, Reid DM 1996 Prediction of perimenopausal fractures by bone mineral density and other risk factors. J Bone Miner Res 11:293-297
14. Lindsay R, Silverman SL, Cooper C, Hanley DA, Barton I, Broy SB, Licata A, Benhamou L, Geusens P, Flowers K, Stracke H, Seeman E 2001 Risk of new vertebral fracture in the year following a fracture. JAMA 285:320-323
15. NIH Consensus Development Panel 2001 Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785-795
16. Jiang Y, Zhao JJ, Mitlak BH, Wang O, Genant HK, Eriksen EF 2003 Teriparatide [recombinant human parathyroid hormone (1-34)] improves both cortical and cancellous bone structure. J Bone Miner Res 18:1932-1941
17. Melton III LJ, Lane AW, Cooper C, Eastell R, O'Fallon WM, Riggs BL 1993 Prevalence and incidence of vertebral deformities. Osteoporos Int 3:113-119